Clinical Trials Logo

Congenital Dysplasia of the Hip clinical trials

View clinical trials related to Congenital Dysplasia of the Hip.

Filter by:
  • None
  • Page 1

NCT ID: NCT04348968 Terminated - Osteoarthritis, Hip Clinical Trials

Maxera Large Cups - Canada

Maxera Canada
Start date: March 1, 2021
Phase:
Study type: Observational

This study is monocentric, retrospective and prospective, non-controlled, consecutive series Post-Market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data of the Largest Zimmer® Maxera™ Cup (Implants and Instrumentation)

NCT ID: NCT04117685 Recruiting - Clinical trials for Congenital Hip Dysplasia

Global Hip Dysplasia Registry

GHDR
Start date: September 1, 2016
Phase:
Study type: Observational

Developmental dysplasia of the hip (DDH) is the most common hip condition affecting infants and children. DDH represents a spectrum of issues affecting the hip joint - a "ball-and-socket" joint. When the femoral head (the "ball) is seated properly in the acetabulum (the "socket"), the hip is stable and can develop normally. However, when the femoral head is not well-seated, the hip can become unstable or dislocate. This instability or dislocation of the femoral head prevents the hip joint from developing normally during infancy and early childhood. If left undetected or untreated, it can lead to debilitating complications later in life. Development of a comprehensive, prospective international registry for all infants and children with DDH will provide the potential to impact all infants born, not only in British Columbia, but around the world. The purpose of this initiative is to identify best practices and standardize treatment and management strategies in order to optimize clinical and functional outcomes for patients with DDH. This registry includes targeted specific outcomes that will be investigated, in addition to the general collection of data on all patients diagnosed with any form of DDH up to the age of 10 years.

NCT ID: NCT02503891 Recruiting - Clinical trials for Rheumatoid Arthritis

AL-2 MP-1 (Polyimide) Acetabular Liner

Start date: September 15, 2017
Phase: N/A
Study type: Interventional

M.M.A.TECH Ltd. product is an Acetabular Liner Family produced of an advanced polyimide - MP-1™. M.M.A.TECH Ltd. produces the Liners according to EN ISO 13485:2012 approved manufacturing process and supplies them to the customer. The aim of this study is to evaluate, in the frame of PMCF, the safety and performance of using AL-X MP1 Polyimide Acetabular liners in Total Hip Replacement surgery by clinical following up of patients for a period of 2 years .

NCT ID: NCT01422564 Terminated - Clinical trials for Rheumatoid Arthritis

Metal on Metal Versus Metal on Highly Crossed Linked Polyethylene Sytem

MOM
Start date: January 2007
Phase: Phase 4
Study type: Interventional

This trial will evaluate the 36mm or greater metal head on metal hip system and compare it to the 32mm or 28mm metal head on polyethylene (liner) hip system in patients receiving a primary cementless total hip replacement.